Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) EBT Margin Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) EBT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 3,356.00
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -2.00
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn 360.00
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 1,689.00
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 4,434.00
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 1,078.00
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 7,507.00
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 1,455.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.00
Mar 31, 2026 -35.00
Dec 31, 2025 709.00
Sep 30, 2025 -247.00
Jun 30, 2025 74.00
Mar 31, 2025 -690.00
Dec 31, 2024 -689.00
Sep 30, 2024 -1,168.00
Jun 30, 2024 -1,894.00
Mar 31, 2024 -1,177.00
Dec 31, 2023 -1,489.00
Sep 30, 2023 -1,400.00
Jun 30, 2023 -40.00
Mar 31, 2023 541.00
Dec 31, 2022 -1,236.00
Sep 30, 2022 32.00
Jun 30, 2022 -40.00
Mar 31, 2022 605.00
Dec 31, 2021 921.00
Sep 30, 2021 949.00